Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.
Cardiovasc Revasc Med. 2023 Aug;53:22-27. doi: 10.1016/j.carrev.2023.03.003. Epub 2023 Mar 11.
Coronary intravascular lithotripsy (IVL) has emerged as a novel technique for the treatment of severely calcified coronary lesions. We evaluated the mechanism and efficacy of IVL in facilitating optimal stent implantation in heavily calcified coronary lesions using intravascular ultrasound (IVUS).
Forty-six patients were initially enrolled as a part of the Disrupt CAD III study. Of these, 33 had pre-IVL, 24 had post-IVL, and 44 had post-stent IVUS evaluation. The final analysis was performed on 18 patients who had IVUS images interpretable at all three intervals. The primary endpoint was increase in minimum lumen area (MLA) from pre-IVL to post-IVL treatment to post-stenting.
Pre-IVL, MLA was 2.75 ± 0.84 mm, percent area stenosis was 67.22 % ± 20.95 % with maximum calcium angle of 266.90° ± 78.30°, confirming severely calcified lesions. After IVL, MLA increased to 4.06 ± 1.41 mm (p = 0.0003), percent area stenosis decreased to 54.80 % ± 25.71 % (p = 0.0009), and maximum calcium angle decreased to 239.40° ± 76.73° (p = 0.003). There was a further increase in MLA to 6.84 ± 2.18 mm (p < 0.0001) and decrease in percent area stenosis to 30.33 % ± 35.08 % (p < 0.0001) post-stenting with minimum stent area of 6.99 ± 2.14 mm. The success rate of stent delivery, implantation, and post-stent dilation was 100 % post-IVL.
In this first study evaluating the mechanism of IVL using IVUS, the primary endpoint of increase in MLA from pre-IVL to post-IVL treatment to post-stenting was successfully achieved. Our study showed that the use of IVL-assisted percutaneous coronary intervention is associated with improved vessel compliance, facilitating optimal stent implantation in de novo severely calcified lesions.
冠状动脉腔内碎石术(IVL)已成为治疗严重钙化冠状动脉病变的一种新方法。我们使用血管内超声(IVUS)评估了 IVL 在促进重度钙化冠状动脉病变中最佳支架植入的机制和效果。
最初有 46 名患者作为 Disrupt CAD III 研究的一部分入组。其中 33 名患者在 IVL 前、24 名患者在 IVL 后、44 名患者在支架置入后进行 IVUS 评估。最终分析了 18 名在所有三个时间点均有可解释 IVUS 图像的患者。主要终点是从 IVL 前到 IVL 后治疗到支架置入后的最小管腔面积(MLA)增加。
IVL 前,MLA 为 2.75±0.84mm,面积狭窄率为 67.22%±20.95%,最大钙角为 266.90°±78.30°,证实病变严重钙化。IVL 后,MLA 增加至 4.06±1.41mm(p=0.0003),面积狭窄率降低至 54.80%±25.71%(p=0.0009),最大钙角降低至 239.40°±76.73°(p=0.003)。支架置入后,MLA 进一步增加至 6.84±2.18mm(p<0.0001),面积狭窄率降低至 30.33%±35.08%(p<0.0001),最小支架面积为 6.99±2.14mm。IVL 后支架输送、植入和支架后扩张的成功率为 100%。
在这项使用 IVUS 评估 IVL 机制的首次研究中,从 IVL 前到 IVL 后治疗到支架置入后的 MLA 增加的主要终点成功实现。我们的研究表明,使用 IVL 辅助经皮冠状动脉介入治疗与改善血管顺应性相关,有利于在新出现的严重钙化病变中最佳地植入支架。